MEDICLIN Reports Stable Nine-Month Performance, Confirms Full-Year Forecast

MEDICLIN AG posted a 4.1% rise in group operating result to EUR 585.9 million and a 7.8% increase in EBIT to EUR 52.7 million for the first nine months of 2026, confirming its full-year guidance despite a challenging market.

Chicago Metrowire Staff
••Healthcare
MEDICLIN Reports Stable Nine-Month Performance, Confirms Full-Year Forecast

MEDICLIN Aktiengesellschaft reported a 4.1 per cent increase in group operating result to EUR 585.9 million for the first nine months of 2026, up from EUR 563.0 million in the prior-year period, according to the company's interim report. Consolidated EBIT rose by EUR 3.8 million to EUR 52.7 million, compared with EUR 48.9 million a year earlier. The results, released via NEWMEDIAWIRE, underscore the resilience of the healthcare provider's business model amid persistent market challenges.

The Post-Acute segment, MEDICLIN's largest, saw operating result grow by 3.5 per cent to EUR 399.6 million, although EBIT in the segment fell 5.9 per cent to EUR 44.8 million due to higher staff costs and a staff cost ratio that climbed to 53.9 per cent from 52.0 per cent. The Acute segment reported a 6.0 per cent rise in operating result to EUR 168.3 million, with EBIT improving to EUR 3.1 million from EUR 0.7 million. The Care segment's operating result dipped slightly to EUR 18.1 million, but EBIT turned positive at EUR 0.6 million. The Service segment contributed EUR 4.2 million in EBIT, up EUR 3.2 million.

The company treated 82,265 patients in the first nine months, up from 81,564 in the same period of 2025. CFO Tino Fritz said the performance confirms the robustness of the business model and positions the company to meet its full-year forecast. MEDICLIN continues to expect a group operating result increase of between 3.5 per cent and 6.5 per cent for 2026, with consolidated EBIT projected between EUR 57.0 million and EUR 72.0 million.

The interim report is available in German and English at www.mediclin.de. For investors, the confirmed outlook signals management confidence in the company's operational strategy despite cost pressures, particularly in staff expenses, which rose 7.3 per cent in the Post-Acute segment. The full release can be viewed on www.newmediawire.com.

Blockchain Registration

QR Code for Blockchain Registration